|
Alonso Adel C, Mederlyova A, Novak M, Grundke-Iqbal I, Iqbal K: Promotion of hyperphosphorylation by frontotemporal dementia tau mutations. J Biol Chem 2004, 279:34873-34881. Alonso A, Zaidi T, Novak M, Grundke-Iqbal I, Iqbal K (June 2001). Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc. Natl. Acad. Sci. U.S.A. 98 (12): 6923–8. Billingsley ML, Kincaid RL. Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem, J 1997. 323 (3): 577–91. Brand AH, Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118: 401–415. Brand AH, Perrimon N. (June 1, 1993). Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118: 401–415. Braak H, Braak E: Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging 1995, 16:271-278. Discussion 278–284 B. Trinczek, A. Ebneth, E.-M. Mandelkow and E. Mandelkow. Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles. Journal of Cell Science 112 (1999), 2355-2367 Campbell RN, Leverentz MK, Ryan LA, Reece RJ. (2008). Metabolic control of Transcription: Paradigms and lessons from Saccharomyces cerevsiae. Biochem J 414 (2): 177-87. Galpern WR, Lang AE. Interface between tauopathies and synucleinopathies: a tale of two proteins. Ann. Neurol 2006. 59 (3): 449–58. Gasser T. Genetics of Parkinson’s disease. J Neurol 2001;248:833–840. Gero Miesenbo¨ck, Dino A. De Angelis & James E. Rothman Cellular Biochemistry and Biophysics Program, Memorial Sloan-Kettering Cancer Center, Visualizing secretion and synaptic transmission with pH-sensitive green fluorescent proteins. 1275 York Avenue, New York, New York 10021, USA Heiko Braaka , Kelly Del Tredicia, Udo Rüba. Staging of brain pathology related to sporadic Parkinson’s disease, Neurobiology of Aging Volume 24, Issue 2, March–April 2003, Pages 197–211 Ishizawa, Matilla, Davies,Wang, Dickso . Colocalization of Tau and Alpha-Synuclein Epitopes in Lewy Bodies. Journal of Neuropathology & Experimental Neurology 2003; 62 (4): 389–397. Janice A. Fischer, Edward Giniger, Tom Maniatis, and Mark Ptashne (1988). GAL4 activates transcription in Drosophila. Nature (6167): 853–6. Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008 Apr;79(4):368-76. Joseph R. Casey, Sergio Grinstein & John Orlowski. Sensors and regulators of intracellular pH, Nature Reviews Molecular Cell Biology 11, 50-61 (January 2010) doi:10.1038/nrm2820 Little KY, Krolewski DM, Zhang L, Cassin BJ. Loss of striatal vesicular monoamine transporter protein (VMAT2) in human cocaine users. Am J Psychiatry 160 (1) 2003: 47–55. doi:10.1176/appi.ajp.160.1.47 Shin RW, Iwaki T, Kitamoto T, Tateishi J. Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues, Lab. Invest 1991. 64 (5): 693–702. Steinhilb ML, Dias-Santagata D, Fulga TA, Felch DL, Feany MB. Mol Biol Cell. 2007.Tau phosphorylation sites work in concert to promote neurotoxicity in vivo. Dec;18(12):5060-8. Epub 2007 Oct 10. Steinhilb ML, Dias-Santagata D, Mulkearns EE, Shulman JM, Biernat J, Mandelkow EM, Feany MB. J Neurosci Res.S/P and T/P phosphorylation is critical for tau neurotoxicity in Drosophila. 2007 May 1;85(6):1271-8. Ted M. Dawson,and Valina L. Dawson. The Role of Parkin in Familial and Sporadic Parkinson’s Disease, Movement Disorders Vol. 25, Suppl. 1, 2010, pp. S32–S39. Webster N, Jin JR, Green S, Hollis M, Chambon P. (1988). The yeast UASG is a transcription enhancer in human HeLa cells in the presence of the GAL4 trans-activator. Cell 52 (2): 169–78. |